// App-Quantinova.ai

: The Burden of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Systematic Literature Review (SLR)

Researchers

Presenter

  • Georg Lenz

Principal Investigators

  • Sarah C. Rutherford

  • Andrew Davies

  • Pier Luigi Zinzani

  • Gilles Salles

  • Jens Hasskarl

  • Sandra Margunato-Debay

  • Filipe Rodrigues

  • Lisette Nientker

  • Janita Balradj

  • Cathelijne Alleman

Medical Centers

  • University Hospital of Muenster, Muenster, Germany

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

  • Cancer Sciences, University of Southampton, Southampton, United Kingdom

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • CHU Lyon Sud, Lyon, France.

  • Celgene Corporation, Boudry, Switzerland

  • Celgene Corporation, Summit, NJ

  • Pharmerit International, Rotterdam, Netherlands

Locations

  • Germany

  • United States

  • United Kingdom

  • Italy

  • France

  • Switzerland

  • Netherlands

Companies

  • Celgene Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved